CRNX stock touches 52-week low at $35.47 amid market shifts
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) stock has reached a 52-week low, trading at $35.47, with InvestingPro technical indicators showing oversold conditions. The stock has declined sharply, ...
hospitalhealthcare3h
Chronic asthma guideline key updates and implications: diagnosis and management
Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.
Irish Examiner on MSN5h
Four signs your cortisol levels are out of control – and six things you can do about it
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
WTVO on MSN12h
‘They just told me I had anxiety’ Belvidere woman battles heart disease after misdiagnosis
February is American Heart Month, and one local woman is using her story to help encourage others to seek medical help if their body does not feel right. Megan ...